Supplementary Figure 22 from Arginase 1/2 inhibitor OATD-02: from discovery to first-in-man setup in cancer immunotherapy

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Supplementary Figure 22 from Arginase 1/2 inhibitor OATD-02: from discovery to first-in-man setup in cancer immunotherapy2024
2. 2Supplementary Figure 23 from Arginase 1/2 inhibitor OATD-02: from discovery to first-in-man setup in cancer immunotherapy2024
3. 3Supplementary Figure 23 from Arginase 1/2 inhibitor OATD-02: from discovery to first-in-man setup in cancer immunotherapy2024
4. 4Supplementary Figure 16 from Arginase 1/2 inhibitor OATD-02: from discovery to first-in-man setup in cancer immunotherapy2024
5. 5Supplementary Figure 16 from Arginase 1/2 inhibitor OATD-02: from discovery to first-in-man setup in cancer immunotherapy2024